PD-1 Axis Inhibition in EGFR Positives: A Blunt Sword?

J Thorac Oncol. 2017 Feb;12(2):171-172. doi: 10.1016/j.jtho.2016.12.013.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • ErbB Receptors
  • Humans
  • Lung Neoplasms*

Substances

  • ErbB Receptors